Apatinib Combined With S-1 for the Treatment of Recurrent/Metastatic Head and Neck Malignancies

Condition:   Head and Neck Cancer Intervention:   Drug: Apatinib Sponsors:   China International Medical Foundation;   Chinese Society of Clinical Oncology Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials